Top Markets
Coin of the day
Theranexus Société Anonyme Theranexus Société Anonyme

Theranexus Société Anonyme

ALTHX
Rank in Stocks #15063
Theranexus société anonyme, a biopharmaceutical company, develops drug... Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.
Share Price
$4.66
Market Cap
$43.92M
Change (1 day)
-0.63%
Change (1 year)
338.04%
Country
FR
Trade Theranexus Société Anonyme (ALTHX)

Category

P/S ratio for Theranexus Société Anonyme (ALTHX)
P/S ratio as of July 2026 TTM: 38.28
According to Theranexus Société Anonyme latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 38.28. At the end of 2023 the company had a P/S ratio of 29.32.
P/S ratio history for Theranexus Société Anonyme from 2015 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
2026 (TTM) 38.28 1,672.34%
2024 2.16 -92.63%
2023 29.32 30.81%
2022 22.42 -99.94%
2021 40.48K 15,636.51%
2020 257.27 1,228.70%
2019 19.36 -96.16%
2018 503.88 58.16%
2017 318.60 108.08%
2016 153.11 519.84%
2015 24.70 0.00%
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
4.26 -88.86%
DK
10.29 -73.13%
US
4.31 -88.75%
US
6.44 -83.17%
BE
16.96 -55.70%
NL